{"id":7940,"date":"2022-09-06T08:45:04","date_gmt":"2022-09-06T08:45:04","guid":{"rendered":"https:\/\/www.dhenne-avocat.sea-dev-and-sun.fr\/2022\/09\/06\/blog-dhenne-avocats-5\/"},"modified":"2022-09-06T08:45:04","modified_gmt":"2022-09-06T08:45:04","slug":"moderna-vs-pfizer-biontech-french-perspective","status":"publish","type":"post","link":"https:\/\/www.dhenne-avocats.fr\/en\/moderna-vs-pfizer-biontech-french-perspective\/","title":{"rendered":"Moderna vs. Pfizer &amp; BioNTech: French perspective"},"content":{"rendered":"<p><strong><em>The news was announced last week: Moderna is suing Pfizer for infringement of two of its patents related to Covid-19 vaccines. These highly targeted actions are likely to spread to many other countries: here is a brief overview of the case and its potential French perspective.<\/em><\/strong><\/p>\n<p>Par <a href=\"https:\/\/www.lemonde.fr\/planete\/article\/2022\/08\/26\/covid-19-moderna-porte-plainte-contre-pfizer-biontech-pour-violation-de-brevet-concernant-leur-vaccin_6139119_3244.html\">un communiqu\u00e9 de presse dat\u00e9 du 26 ao\u00fbt 2022<\/a>, <strong>Moderna indiquait qu\u2019elle intentait deux actions en <a href=\"https:\/\/www.dhenne-avocats.fr\/en\/lexique-propriete-industrielle\/patent-infringement\/\">contrefa\u00e7on de brevets<\/a> \u00e0 l\u2019encontre de son concurrent Pfizer et BioNTech<\/strong>.<\/p>\n<p>Ces actions, qui ont \u00e9t\u00e9 introduites aux \u00c9tats-Unis et en Allemagne &#8211; devant le Tribunal du district du Massachusetts et le Tribunal r\u00e9gional de D\u00fcsseldorf &#8211; visent deux techniques relatives \u00e0 l\u2019ARN messager (\u00ab\u00a0<i>ARNm<\/i>\u00a0\u00bb) qui, selon Moderna, auraient \u00e9t\u00e9 reproduites par Pfizer et BioNTech lors de la r\u00e9alisation de leur vaccin Comirnaty\u00ae.<\/p>\n<p><strong>La premi\u00e8re technique mise en cause consiste dans\u00a0une structure d\u2019ARN messager que Moderna a commenc\u00e9 \u00e0 d\u00e9velopper en\u00a02010 et dont les essais sur l\u2019Homme ont \u00e9t\u00e9 valid\u00e9s d\u00e8s 2015\u00a0: une modification chimique sp\u00e9cifique de l\u2019ARNm<\/strong>. Pfizer et BioNTech auraient, selon la demanderesse, fait passer quatre candidats vaccins diff\u00e9rents en phase d\u2019essais cliniques, dont certaines options qui auraient \u00e9vit\u00e9 la voie inventive de Moderna. Cependant, Pfizer et BioNTech ont en fin de compte choisi de r\u00e9aliser un vaccin dont la modification chimique de l\u2019ARNm est exactement la m\u00eame que celle de son Spikevax\u00ae.<\/p>\n<p><strong>La seconde technique mise en cause consiste dans le codage d\u2019une prot\u00e9ine dite \u00ab\u00a0<i>Spike<\/i>\u00a0\u00bb compl\u00e8te r\u00e9alis\u00e9 par les \u00e9quipes de Moderna<\/strong>. De m\u00eame, bien qu\u2019ils avaient d\u2019autres options possibles, Pfizer et BioNTech auraient pr\u00e9f\u00e9r\u00e9 reproduire l\u2019approche de Moderna, afin de coder la prot\u00e9ine spike compl\u00e8te dans une formulation de nanoparticules lipidiques pour un coronavirus. Or, les scientifiques de Moderna avaient d\u00e9velopp\u00e9 cette approche lorsqu\u2019ils ont cr\u00e9\u00e9 un vaccin contre le coronavirus \u00e0 l\u2019origine du syndrome respiratoire du Moyen-Orient (MERS).<\/p>\n<p><strong>L\u2019enjeu est de taille\u00a0: <a href=\"https:\/\/fr.wikipedia.org\/wiki\/Acide_ribonucl\u00e9ique_messager\">l\u2019ARN messager constitue une technique r\u00e9volutionnaire<\/a><\/strong>, qui pourra \u00eatre utilis\u00e9e dans de nombreuses autres recherches que celles li\u00e9es au Covid-19, et qui constitue d\u00e9j\u00e0 un v\u00e9ritable changement de paradigme dans la recherche de vaccins, dont les m\u00e9thodes traditionnelles consistaient \u00e0 utiliser des formes affaiblies ou d\u00e9sactiv\u00e9es des virus.<\/p>\n<p>De fait, <strong>les actions en <a href=\"https:\/\/www.dhenne-avocats.fr\/en\/lexique-propriete-industrielle\/infringement\/\">Infrigement<\/a> ont essentiellement deux buts<\/strong>\u00a0: garantir l\u2019exclusivit\u00e9 de Moderna sur deux techniques fondamentales relatives \u00e0 l\u2019ARNm\u00a0; obtenir des dommages et int\u00e9r\u00eats, mais surtout des royalties (ou redevances, autrement dit chaque personne qui utilisera ces deux techniques devra s\u2019acquitter desdites redevances qui correspondront \u00e0 un pourcentage du prix de vente du produit impliquant l\u2019utilisation de la technique).<\/p>\n<p><strong>En tout \u00e9tat de cause, ces actions sont tr\u00e8s cibl\u00e9es dans le temps et dans l\u2019espace\u00a0<\/strong>: elles ne concernent que deux pays (les \u00c9tats-Unis et l\u2019Allemagne), n\u2019incluent pas les demandes d\u2019interdictions provisoires \u00e0 la vente, et excluent les 92 pays \u00e0 revenu faible ou interm\u00e9diaire \u00e9ligibles \u00e0 l\u2019AMC (Advance Market Commitment for Covid-19 Vaccines), et la p\u00e9riode prise en compte ne commence qu\u2019en mars 2022 (Moderna s\u2019\u00e9tant jusqu\u2019alors engag\u00e9e \u00e0 donner acc\u00e8s \u00e0 ses <a href=\"https:\/\/www.dhenne-avocats.fr\/en\/lexique-propriete-industrielle\/patent\/\">Patent<\/a> gratuitement, mais sous certaines conditions avec sa promesse de brevet).<\/p>\n<p><strong>Cela \u00e9tant, il y a de fortes chances que des actions de ce type prosp\u00e8rent dans de nombreux pays<\/strong>. En effet, il s\u2019agit de contentieux particuli\u00e8rement longs. Or, en Europe, si on prend le cas de l\u2019Allemagne, les proc\u00e9dures sont souvent bloqu\u00e9es pendant plusieurs ann\u00e9es, parce que les d\u00e9fenderesses demandent la nullit\u00e9 des brevets, ce qui peut bloquer l\u2019action principale en contrefa\u00e7on, si le Juge de la contrefa\u00e7on d\u00e9cide de ne pas statuer avant que la Juge de la validit\u00e9 n\u2019ait rendu sa d\u00e9cision (ce qui est loin d\u2019\u00eatre rare dans des affaires d\u2019une telle importance).<\/p>\n<p>En revanche, <strong>il ne serait pas exclu que Moderna intente une action plus prompte en France, par exemple, o\u00f9 la validit\u00e9 de ses brevets seraient directement examin\u00e9s par les Juges en m\u00eame temps que la contrefa\u00e7on<\/strong>. Une action sur le territoire fran\u00e7ais pourrait m\u00eame \u00eatre \u00e9claire, si Moderna se d\u00e9cidait \u00e0 demandait une interdiction provisoire \u00e0 la vente en France\u00a0: dans ce cas en quelques mois un Juge se prononcerait sur la contrefa\u00e7on et sur la validit\u00e9 de ses Brevets et pourrait m\u00eame accorder des dommages et int\u00e9r\u00eats provisionnels \u00e0 Moderna.<\/p>\n<p>Ainsi, <strong>l&rsquo;on ne peut pas exclure que, dans les nombreux rebondissements que comprendra cette affaire, Moderna n\u2019envisage pas, notamment, de demander une interdiction provisoire en France, o\u00f9, en quelques mois, ses Brevets pourraient \u00eatre reconnus valides, et Pfizer BioNtech interdite \u00e0 la vente<\/strong>, certainement oblig\u00e9es d\u00e8s lors de n\u00e9gocier, au moins pour \u00eatre en mesure de vendre en France.<\/p>","protected":false},"excerpt":{"rendered":"<p>La nouvelle a \u00e9t\u00e9 annonc\u00e9e le 26 ao\u00fbt 2022\u00a0: Moderna attaque Pfizer et BioNTech en contrefa\u00e7on de deux de ses brevets relatifs aux vaccins Covid-19. Ces actions tr\u00e8s cibl\u00e9es risquent de s\u2019\u00e9tendre \u00e0 de nombreux autres pays. Que cela signifie-t-il pr\u00e9cis\u00e9ment\u00a0? Cette guerre dans le secteur pharmaceutique pourrait-elle, notamment, avoir des r\u00e9percussions sur les approvisionnements [&hellip;]<\/p>","protected":false},"author":5,"featured_media":7938,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[16,8,19,24,25],"tags":[],"class_list":["post-7940","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-brevets","category-covid-19","category-dommages-et-interets","category-forum-shopping","category-patent-pledge"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets - Dhenne Avocats<\/title>\n<meta name=\"description\" content=\"Lisez l&#039;article : Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets du blog Dhenne Avocats\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.dhenne-avocats.fr\/en\/moderna-vs-pfizer-biontech-french-perspective\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets - Dhenne Avocats\" \/>\n<meta property=\"og:description\" content=\"Lisez l&#039;article : Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets du blog Dhenne Avocats\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.dhenne-avocats.fr\/en\/moderna-vs-pfizer-biontech-french-perspective\/\" \/>\n<meta property=\"og:site_name\" content=\"Dhenne Avocats\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-06T08:45:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_220120304-scaled-2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"eajvi7G6Zv5P9\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"eajvi7G6Zv5P9\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/\"},\"author\":{\"name\":\"eajvi7G6Zv5P9\",\"@id\":\"https:\/\/www.dhenne-avocats.fr\/#\/schema\/person\/5a7426c68f341a547a6d8e49fe07cea7\"},\"headline\":\"Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets\",\"datePublished\":\"2022-09-06T08:45:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/\"},\"wordCount\":845,\"publisher\":{\"@id\":\"https:\/\/www.dhenne-avocats.fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_220120304-scaled-2.jpeg\",\"articleSection\":[\"Brevets\",\"covid-19\",\"Dommages et int\u00e9r\u00eats\",\"Forum shopping\",\"patent pledge\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/\",\"url\":\"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/\",\"name\":\"Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets - Dhenne Avocats\",\"isPartOf\":{\"@id\":\"https:\/\/www.dhenne-avocats.fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_220120304-scaled-2.jpeg\",\"datePublished\":\"2022-09-06T08:45:04+00:00\",\"description\":\"Lisez l'article : Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets du blog Dhenne Avocats\",\"breadcrumb\":{\"@id\":\"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/#primaryimage\",\"url\":\"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_220120304-scaled-2.jpeg\",\"contentUrl\":\"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_220120304-scaled-2.jpeg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.dhenne-avocats.fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.dhenne-avocats.fr\/#website\",\"url\":\"https:\/\/www.dhenne-avocats.fr\/\",\"name\":\"Dhenne Avocats\",\"description\":\"Cabinet d&#039;avocats en droit des brevets\",\"publisher\":{\"@id\":\"https:\/\/www.dhenne-avocats.fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.dhenne-avocats.fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.dhenne-avocats.fr\/#organization\",\"name\":\"Dhenne Avocats\",\"alternateName\":\"dhenne avocats\",\"url\":\"https:\/\/www.dhenne-avocats.fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.dhenne-avocats.fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/cropped-DhenneAvocats_Favicon_RVB_FullColor-1.png\",\"contentUrl\":\"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/cropped-DhenneAvocats_Favicon_RVB_FullColor-1.png\",\"width\":512,\"height\":512,\"caption\":\"Dhenne Avocats\"},\"image\":{\"@id\":\"https:\/\/www.dhenne-avocats.fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.dhenne-avocats.fr\/#\/schema\/person\/5a7426c68f341a547a6d8e49fe07cea7\",\"name\":\"eajvi7G6Zv5P9\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.dhenne-avocats.fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/faaaaacf01055ee63a78e37c3014f990f3235015c2bdef148e716a6a8e39a842?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/faaaaacf01055ee63a78e37c3014f990f3235015c2bdef148e716a6a8e39a842?s=96&d=mm&r=g\",\"caption\":\"eajvi7G6Zv5P9\"},\"sameAs\":[\"https:\/\/www.dhenne-avocats.fr\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets - Dhenne Avocats","description":"Lisez l'article : Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets du blog Dhenne Avocats","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.dhenne-avocats.fr\/en\/moderna-vs-pfizer-biontech-french-perspective\/","og_locale":"en_GB","og_type":"article","og_title":"Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets - Dhenne Avocats","og_description":"Lisez l'article : Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets du blog Dhenne Avocats","og_url":"https:\/\/www.dhenne-avocats.fr\/en\/moderna-vs-pfizer-biontech-french-perspective\/","og_site_name":"Dhenne Avocats","article_published_time":"2022-09-06T08:45:04+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_220120304-scaled-2.jpeg","type":"image\/jpeg"}],"author":"eajvi7G6Zv5P9","twitter_card":"summary_large_image","twitter_misc":{"Written by":"eajvi7G6Zv5P9","Estimated reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/#article","isPartOf":{"@id":"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/"},"author":{"name":"eajvi7G6Zv5P9","@id":"https:\/\/www.dhenne-avocats.fr\/#\/schema\/person\/5a7426c68f341a547a6d8e49fe07cea7"},"headline":"Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets","datePublished":"2022-09-06T08:45:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/"},"wordCount":845,"publisher":{"@id":"https:\/\/www.dhenne-avocats.fr\/#organization"},"image":{"@id":"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_220120304-scaled-2.jpeg","articleSection":["Brevets","covid-19","Dommages et int\u00e9r\u00eats","Forum shopping","patent pledge"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/","url":"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/","name":"Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets - Dhenne Avocats","isPartOf":{"@id":"https:\/\/www.dhenne-avocats.fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/#primaryimage"},"image":{"@id":"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_220120304-scaled-2.jpeg","datePublished":"2022-09-06T08:45:04+00:00","description":"Lisez l'article : Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets du blog Dhenne Avocats","breadcrumb":{"@id":"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/#primaryimage","url":"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_220120304-scaled-2.jpeg","contentUrl":"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_220120304-scaled-2.jpeg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/www.dhenne-avocats.fr\/blog-dhenne-avocats-5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.dhenne-avocats.fr\/"},{"@type":"ListItem","position":2,"name":"Vaccins Covid-19 : Moderna accuse Pfizer-BioNTech de contrefaire ses brevets"}]},{"@type":"WebSite","@id":"https:\/\/www.dhenne-avocats.fr\/#website","url":"https:\/\/www.dhenne-avocats.fr\/","name":"Dhenne Avocats","description":"Cabinet d&#039;avocats en droit des brevets","publisher":{"@id":"https:\/\/www.dhenne-avocats.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.dhenne-avocats.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.dhenne-avocats.fr\/#organization","name":"Dhenne Avocats","alternateName":"dhenne avocats","url":"https:\/\/www.dhenne-avocats.fr\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.dhenne-avocats.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/cropped-DhenneAvocats_Favicon_RVB_FullColor-1.png","contentUrl":"https:\/\/www.dhenne-avocats.fr\/wp-content\/uploads\/2024\/03\/cropped-DhenneAvocats_Favicon_RVB_FullColor-1.png","width":512,"height":512,"caption":"Dhenne Avocats"},"image":{"@id":"https:\/\/www.dhenne-avocats.fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.dhenne-avocats.fr\/#\/schema\/person\/5a7426c68f341a547a6d8e49fe07cea7","name":"eajvi7G6Zv5P9","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.dhenne-avocats.fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/faaaaacf01055ee63a78e37c3014f990f3235015c2bdef148e716a6a8e39a842?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/faaaaacf01055ee63a78e37c3014f990f3235015c2bdef148e716a6a8e39a842?s=96&d=mm&r=g","caption":"eajvi7G6Zv5P9"},"sameAs":["https:\/\/www.dhenne-avocats.fr"]}]}},"_links":{"self":[{"href":"https:\/\/www.dhenne-avocats.fr\/en\/wp-json\/wp\/v2\/posts\/7940","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dhenne-avocats.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dhenne-avocats.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dhenne-avocats.fr\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dhenne-avocats.fr\/en\/wp-json\/wp\/v2\/comments?post=7940"}],"version-history":[{"count":0,"href":"https:\/\/www.dhenne-avocats.fr\/en\/wp-json\/wp\/v2\/posts\/7940\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.dhenne-avocats.fr\/en\/wp-json\/wp\/v2\/media\/7938"}],"wp:attachment":[{"href":"https:\/\/www.dhenne-avocats.fr\/en\/wp-json\/wp\/v2\/media?parent=7940"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dhenne-avocats.fr\/en\/wp-json\/wp\/v2\/categories?post=7940"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dhenne-avocats.fr\/en\/wp-json\/wp\/v2\/tags?post=7940"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}